Literature DB >> 28832350

Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?

Andrew L Mammen1.   

Abstract

PURPOSE OF REVIEW: To discuss the spectrum of nonautoimmune myopathies that may be misdiagnosed as autoimmune myopathy. RECENT
FINDINGS: Inherited myopathies, such as dysferlinopathy, calpainopathy, and facioscapulohumeral dystrophy may be misdiagnosed as autoimmune myopathy, especially when they have inflammatory muscle biopsies. Inclusion body myositis is frequently misdiagnosed as polymyositis when rimmed vacuoles are absent on muscle biopsy, and a careful neuromuscular evaluation is not performed. Hypothyroid myopathy can be misdiagnosed as immune-mediated necrotizing myopathy if thyroid function tests, including a T4 level, are not obtained. Self-limited statin myopathy can be distinguished from statin-associated autoimmune myopathy because patients with the former do not have autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
SUMMARY: Autoimmune myopathies can usually be distinguished from nonautoimmune myopathies based on a combination of the patient history, neuromuscular exam, laboratory findings, and/or muscle biopsy features.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28832350      PMCID: PMC5814131          DOI: 10.1097/BOR.0000000000000441

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  27 in total

1.  Necrotizing myopathy caused by central hypothyroidism.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-06-01       Impact factor: 3.217

2.  More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Eleni Tiniakou; Iago Pinal-Fernandez; Thomas E Lloyd; Jemima Albayda; Julie Paik; Jessie L Werner; Cassie A Parks; Livia Casciola-Rosen; Lisa Christopher-Stine; Andrew L Mammen
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

Review 3.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

4.  Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.

Authors:  K Arahata; T Ishihara; H Fukunaga; S Orimo; J H Lee; K Goto; I Nonaka
Journal:  Muscle Nerve Suppl       Date:  1995

5.  Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Authors:  Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Journal:  Cardiovasc Drugs Ther       Date:  2005-12       Impact factor: 3.727

6.  Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.

Authors:  Andrew L Mammen; Katherine Pak; Emma K Williams; Diane Brisson; Joe Coresh; Elizabeth Selvin; Daniel Gaudet
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-02       Impact factor: 4.794

7.  Calpainopathy with macrophage-rich, regional inflammatory infiltrates.

Authors:  Peter W Schutz; Renata S Scalco; Rita Barresi; Henry Houlden; Matthew Parton; Janice L Holton
Journal:  Neuromuscul Disord       Date:  2017-04-27       Impact factor: 4.296

8.  Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry.

Authors:  Alejandro Lucia; Jonatan R Ruiz; Alfredo Santalla; Gisela Nogales-Gadea; Juan C Rubio; Inés García-Consuegra; Ana Cabello; Margarita Pérez; Susana Teijeira; Irene Vieitez; Carmen Navarro; Joaquín Arenas; Miguel A Martin; Antoni L Andreu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-16       Impact factor: 10.154

9.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.

Authors:  Nizar Chahin; Andrew G Engel
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

10.  Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.

Authors:  Thomas E Lloyd; Iago Pinal-Fernandez; E Harlan Michelle; Lisa Christopher-Stine; Katherine Pak; Ned Sacktor; Andrew L Mammen
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

View more
  6 in total

Review 1.  A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features.

Authors:  Mark M Zaki; Zain M Virk; Diego Lopez; Jenna Klubnick; Jared T Ahrendsen; Hemant Varma; Vasileios Kyttaris; Ilana Abeles
Journal:  Eur J Rheumatol       Date:  2021-01-01

2.  [Clinical and pathological characteristics of immune mediated necrotizing myopathy].

Authors:  H X Yang; X L Tian; W Jiang; W L Li; Q Y Liu; Q L Peng; G C Wang; X Lu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

Review 3.  A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting.

Authors:  Ali Al Shehri; Abdullah Al-Asmi; Abdullah Mohammed Al Salti; Abubaker Almadani; Ali Hassan; Ahmed K Bamaga; Edward J Cupler; Jasem Al-Hashel; Majed M Alabdali; Mohammed H Alanazy; Suzan Noori
Journal:  J Neuromuscul Dis       Date:  2022

Review 4.  Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.

Authors:  Cecilia Contreras-Cubas; Francisco Barajas-Olmos; Maria Inés Frayre-Martínez; Georgina Siordia-Reyes; Claudia C Guízar-Sánchez; Humberto García-Ortiz; Lorena Orozco; Vicente Baca
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

Review 5.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

6.  Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.

Authors:  Hongxia Yang; Xiaolan Tian; Lining Zhang; Wenli Li; Qingyan Liu; Wei Jiang; Qinglin Peng; Guochun Wang; Xin Lu
Journal:  BMC Musculoskelet Disord       Date:  2022-05-06       Impact factor: 2.562

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.